Skip to content

Efficacy and safety of percutaneous vagal nerve stimulation (taVNS) in elderly patients with carotid endarterectomy

Efficacy and safety of percutaneous vagal nerve stimulation (taVNS) in elderly patients with carotid endarterectomy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100114
Enrollment
Unknown
Registered
2025-04-02
Start date
2025-04-07
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This study was conducted in elderly patients (65 to 80 years old) undergoing carotid endarterectomy (CEA) with a background of atherosclerotic carotid stenosis requiring CEA to prevent ischemic stroke. The central nervous system complications were mainly concerned, including stroke, asymptomatic cerebral infarction and cerebral hyperperfusion syndrome. Postoperative neurocognitive decline (PNCD),

Interventions

TaVNS group:Transcutaneous vagal nerve stimulation
StaVNS:Transcutaneous vagus nerve pseudostimulation

Sponsors

Xuzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 65-80 years old; 2.ASAI~III grade; 3.Patients undergoing carotid endarterectomy at selected time; 4. No previous history of cerebral infarction and transient ischemic attack; 5.willing to participate in this experiment, sign the informed consent;

Exclusion criteria

Exclusion criteria: 1. Preoperative arrhythmia (bradycardia (HR<55bpm) and conduction block); 2. The skin at the site of vagus nerve is damaged, redness, infection, etc; 3. Severe vision, hearing, or speech problems, unable to complete a neuropsychological assessment; 4. Cognitive impairment (MMSE < 18);

Design outcomes

Primary

MeasureTime frame
Incidence of central nervous system complications;

Secondary

MeasureTime frame
Postoperative recovery quality;Occult cerebral infarction;depressed;Cognitive Function Improvement (POCI);Cerebral hyperperfusion syndrome;Stroke;Sleep quality;Cranial nerve injury;Pain VAS scale;anxiety;Postoperative neurocognitive Decline (PNCD);Postoperative delirium;

Countries

China

Contacts

Public ContactMeiyan Zhou

Xuzhou Central Hospital

zhouyongxia888@126.com+86 516 83956181

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026